诊断:三尖瓣反流。下一个步骤。

IF 5.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL American Journal of Medicine Pub Date : 2025-07-01 Epub Date: 2025-02-13 DOI:10.1016/j.amjmed.2025.02.006
Daniel M. Gelfman MD, FACC, FACP
{"title":"诊断:三尖瓣反流。下一个步骤。","authors":"Daniel M. Gelfman MD, FACC, FACP","doi":"10.1016/j.amjmed.2025.02.006","DOIUrl":null,"url":null,"abstract":"<div><div>Valvular heart disease is a common problem seen by primary care providers (PCPs). Transcatheter techniques used in the treatment of valvular heart disease have evolved lowering the risk of intervention. This allows for safer valve repair or replacement. Successful transcatheter valvular intervention is truly incredible. These lower-risk procedures are changing who and when to refer patients, as intervention may be safer than the risk of waiting. This issue is most critical in isolated chronic tricuspid regurgitation, as these patients were often felt to be too high risk for tricuspid surgical intervention. Now there exist multiple transcatheter interventions that can benefit patients with tricuspid regurgitation and right ventricular failure. Many of these procedures are still undergoing study and yet, it appears clear that patients receive benefit from intervention. In addition, many patients with chronic tricuspid regurgitation and right ventricular failure are no longer seen by cardiology. It is imperative that PCPs are aware of which patients could potentially benefit from tricuspid valve intervention for tricuspid regurgitation for optimal referral and treatment.</div></div>","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":"138 7","pages":"Pages 1078-1081"},"PeriodicalIF":5.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis: Tricuspid Regurgitation. Next Steps\",\"authors\":\"Daniel M. Gelfman MD, FACC, FACP\",\"doi\":\"10.1016/j.amjmed.2025.02.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Valvular heart disease is a common problem seen by primary care providers (PCPs). Transcatheter techniques used in the treatment of valvular heart disease have evolved lowering the risk of intervention. This allows for safer valve repair or replacement. Successful transcatheter valvular intervention is truly incredible. These lower-risk procedures are changing who and when to refer patients, as intervention may be safer than the risk of waiting. This issue is most critical in isolated chronic tricuspid regurgitation, as these patients were often felt to be too high risk for tricuspid surgical intervention. Now there exist multiple transcatheter interventions that can benefit patients with tricuspid regurgitation and right ventricular failure. Many of these procedures are still undergoing study and yet, it appears clear that patients receive benefit from intervention. In addition, many patients with chronic tricuspid regurgitation and right ventricular failure are no longer seen by cardiology. It is imperative that PCPs are aware of which patients could potentially benefit from tricuspid valve intervention for tricuspid regurgitation for optimal referral and treatment.</div></div>\",\"PeriodicalId\":50807,\"journal\":{\"name\":\"American Journal of Medicine\",\"volume\":\"138 7\",\"pages\":\"Pages 1078-1081\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002934325000853\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002934325000853","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

瓣膜性心脏病是初级保健提供者(pcp)常见的问题。经导管技术用于治疗瓣膜性心脏病的发展降低了干预的风险。这样可以进行更安全的阀门维修或更换。成功的经导管瓣膜介入治疗确实令人难以置信。这些低风险的程序正在改变转诊病人的人选和时间,因为干预可能比等待的风险更安全。这个问题在孤立的慢性三尖瓣反流中最为关键,因为这些患者通常被认为三尖瓣手术干预的风险太高。现在有多种经导管介入治疗可以使三尖瓣反流和右心衰患者受益。其中许多方法仍在研究中,但显然患者从干预中获益。此外,许多慢性三尖瓣反流和右心衰的患者在心脏病学上不再被发现。pcp必须了解哪些患者可能从三尖瓣介入治疗三尖瓣反流中获益,以获得最佳转诊和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Diagnosis: Tricuspid Regurgitation. Next Steps
Valvular heart disease is a common problem seen by primary care providers (PCPs). Transcatheter techniques used in the treatment of valvular heart disease have evolved lowering the risk of intervention. This allows for safer valve repair or replacement. Successful transcatheter valvular intervention is truly incredible. These lower-risk procedures are changing who and when to refer patients, as intervention may be safer than the risk of waiting. This issue is most critical in isolated chronic tricuspid regurgitation, as these patients were often felt to be too high risk for tricuspid surgical intervention. Now there exist multiple transcatheter interventions that can benefit patients with tricuspid regurgitation and right ventricular failure. Many of these procedures are still undergoing study and yet, it appears clear that patients receive benefit from intervention. In addition, many patients with chronic tricuspid regurgitation and right ventricular failure are no longer seen by cardiology. It is imperative that PCPs are aware of which patients could potentially benefit from tricuspid valve intervention for tricuspid regurgitation for optimal referral and treatment.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Medicine
American Journal of Medicine 医学-医学:内科
CiteScore
6.30
自引率
3.40%
发文量
449
审稿时长
9 days
期刊介绍: The American Journal of Medicine - "The Green Journal" - publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. AJM is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprising internal medicine department chairs at more than 125 medical schools across the U.S. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance and position papers on health care issues, medical education, and public policy.
期刊最新文献
The wisdom of medical aphorisms, Part 2 Double strike of the great mimicker: A case of bone and lung melioidosis When looking for treatable diseases, don’t forget the jugular veins Status quo bias and creativity in health and medicine Intestinal microbiomal-derived extracellular vesicles: Broadly systemic messengers from the gut
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1